Authors:
HUMAR A
WOOD S
LIPTON J
MESSNER H
MEHARCHAND J
MCGEER A
MACDONALD K
MAZZULLI T
Citation: A. Humar et al., EFFECT OF CYTOMEGALOVIRUS-INFECTION ON 1-YEAR MORTALITY-RATES AMONG RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS, Clinical infectious diseases, 26(3), 1998, pp. 606-610
Authors:
KAHR WH
ALHOMADHI A
MEHARCHAND J
BAILEY DJ
STEWART AK
Citation: Wh. Kahr et al., TESTICULAR PLASMACYTOMA FOLLOWING CHEMICAL ORCHIECTOMY - POTENTIAL ROLE OF HYPOGONADISM IN MYELOMA PROLIFERATION, Leukemia & lymphoma, 28(3-4), 1998, pp. 437-442
Authors:
SCHIMMER AD
STEWART AK
KEATING A
MACKINNON J
CRUMP M
SUTTON DM
SHEPHERD FA
MEHARCHAND J
Citation: Ad. Schimmer et al., SAFETY OF THERAPEUTIC ANTICOAGULATION IN PATIENTS WITH MULTIPLE-MYELOMA RECEIVING AUTOLOGOUS STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 22(5), 1998, pp. 491-494
Authors:
COUBAN S
STEWART AK
LOACH D
PANZARELLA T
MEHARCHAND J
Citation: S. Couban et al., AUTOLOGOUS AND ALLOGENEIC TRANSPLANTATION FOR MULTIPLE-MYELOMA AT A SINGLE-CENTER, Bone marrow transplantation, 19(8), 1997, pp. 783-789
Authors:
PATTERSON B
MEHARCHAND J
BLANCHETTE V
FREEDMAN J
FRANCOMBE W
HANNACH B
HERST R
LAU W
SHER G
MCDEVITT L
SHULMAN L
BOYCE N
TASEV T
PINCHEFSKY E
PINCHEFSKY J
PANZARELLA T
Citation: B. Patterson et al., NONHEMOLYTIC PLATELET TRANSFUSION REACTIONS - AN OBSERVATIONAL STUDY OF 1,458 PLATELET TRANSFUSIONS TO HEMATOLOGY ONCOLOGY PATIENTS IN TEACHING HOSPITALS/, Transfusion, 37(9), 1997, pp. 150-150
Authors:
SCHIMMER AD
MACKINNON J
MEHARCHAND J
KEATING A
CRUMP RM
SUTTON DM
SHEPHERD FA
STEWART AK
Citation: Ad. Schimmer et al., SAFETY OF THERAPEUTIC ANTICOAGULATION IN PATIENTS WITH MULTIPLE-MYELOMA RECEIVING AUTOLOGOUS STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4387-4387
Authors:
SHUSTIK C
JOHNSTON D
JAMES K
ZEE B
MYER R
BELCH A
KLASA R
MEHARCHAND J
PATER J
Citation: C. Shustik et al., GLUCOCORTICOID DOSE-RELATED SUSCEPTIBILITY TO INFECTION IN MYELOMA PATIENTS TREATED WITH MELPHALAN, Blood, 90(10), 1997, pp. 1596-1596
Authors:
SIMPSON DR
BERKAHN LC
SQUIRE J
MEHARCHAND J
DUBE ID
SUTTON DM
CRUMP RM
KEATING A
STEWART AK
Citation: Dr. Simpson et al., PROGNOSTIC-SIGNIFICANCE OF CYTOGENETICS IN PATIENTS WITH MULTIPLE-MYELOMA REFERRED FOR AUTOLOGOUS STEM-CELL TRANSPLANT (ABMT), Blood, 90(10), 1997, pp. 2349-2349
Authors:
PRINCE HM
IMRIE K
SUTHERLAND DR
KEATING A
MEHARCHAND J
CRUMP RM
GIROUARD C
TRIP K
STEWART AK
Citation: Hm. Prince et al., PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS IN MULTIPLE-MYELOMA - PREDICTORS AND MANAGEMENT OF INADEQUATE COLLECTIONS, British Journal of Haematology, 93(1), 1996, pp. 142-145
Authors:
LOWSKY R
FYLES G
MINDEN M
LIPTON J
MEHARCHAND J
TEJPAR I
ZIPURSKY A
MESSNER H
Citation: R. Lowsky et al., DETECTION OF DONOR CELL-DERIVED ACUTE MYELOGENOUS LEUKEMIA IN A PATIENT TRANSPLANTED FOR CHRONIC MYELOGENOUS LEUKEMIA USING FLUORESCENCE IN-SITU HYBRIDIZATION, British Journal of Haematology, 93(1), 1996, pp. 163-165
Authors:
COUBAN S
STEWART AK
LOACH D
PANZARELLA T
MESSNER HA
KEATING A
MEHARCHAND J
Citation: S. Couban et al., AUTOLOGOUS (AUTO) AND ALLOGENEIC (ALLO) BONE-MARROW (BMT) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPCT) TRANSPLANTATION FOR MYELOMA, Blood, 88(10), 1996, pp. 2463-2463
Authors:
PRINCE HM
IMRIE K
KEATING A
MEHARCHAND J
STEWART AK
Citation: Hm. Prince et al., THE INFLUENCE OF PRIOR ALKYLATING AGENT THERAPY ON THE COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN MULTIPLE-MYELOMA, Experimental hematology, 23(8), 1995, pp. 755-755
Authors:
MACKINNON J
MEHARCHAND J
BRANDWEIN J
SUTTON D
STEWART AK
Citation: J. Mackinnon et al., PHASE-I STUDY OF MITOXANTRONE, VINCRISTINE AND DECADRON FOLLOWING REVERSAL OF MULTIDRUG-RESISTANCE BY CYCLOSPORINE-A (C-MOD) IN THE TREATMENT OF CHEMOTHERAPY REFRACTORY MULTIPLE-MYELOMA, Blood, 86(10), 1995, pp. 3337-3337
Authors:
REDDY VS
RAO R
LIPTON J
HAO Y
FYLES G
TEJPAR I
MINDEN MD
ATKINS H
MEHARCHAND J
MESSNER HA
Citation: Vs. Reddy et al., TOXICITY AND OUTCOME OF BUSULFAN AND CYCLOPHOSPHAMIDE PREPARATIVE REGIMEN IN BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 3834-3834
Authors:
LOWSKY R
LIPTON J
FYLES G
MINDEN M
MEHARCHAND J
TEJPAR I
ATKINS H
SUTCLIFFE S
MESSNER H
Citation: R. Lowsky et al., SECONDARY MALIGNANCIES AFTER BONE-MARROW TRANSPLANTATION IN ADULTS, Journal of clinical oncology, 12(10), 1994, pp. 2187-2192
Authors:
MESSNER HA
ATKINS H
CURTIS H
FYLES G
LIPTON J
MEHARCHAND J
MINDEN MD
TEIPAR I
HAO Y
Citation: Ha. Messner et al., IMPROVEMENT OF DISEASE-FREE SURVIVAL IN BONE-MARROW TRANSPLANT RECIPIENTS WITH AML IN FIRST-CHRONIC PHASE - A REFLECTION OF IMPROVED SUPPORTIVE CARE, Experimental hematology, 22(8), 1994, pp. 692-692
Authors:
MESSNER HA
KEATING A
STEWART J
LIPTON J
CURTIS J
MINDEN MD
CRUMP M
MEHARCHAND J
Citation: Ha. Messner et al., INTERFERON IN THE MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA, Experimental hematology, 22(8), 1994, pp. 797-797
Authors:
LIPTON J
PATTERSON B
MUSTARD R
TEJPAR I
FYLES G
MEHARCHAND J
MESSNER H
Citation: J. Lipton et al., PNEUMATOSIS-INTESTINALIS WITH FREE-AIR MIMICKING INTESTINAL PERFORATION IN A BONE-MARROW TRANSPLANT PATIENT, Bone marrow transplantation, 14(2), 1994, pp. 323-326